Laura Mezquita
Grup de recerca
- Genòmica translacional i teràpies dirigides en tumors sòlids Junior researcher (R2B)
Publicacions destacades
-
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer
Autors:Referència: Lung Cancer 2023. -
Effects of spatial variation in dose delivery: what can we learn from radon-related lung cancer studies?
Autors:Referència: Radiation And Environmental Biophysics 2022. -
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics
Autors:Referència: European Journal Of Cancer 2021. -
Circulating Tumor DNA Genomics Reveal Potential Mechanisms of Resistance to BRAF-Targeted Therapies in Patients with BRAF-Mutant Metastatic Non-Small Cell Lung Cancer
Autors:Referència: Clinical Cancer Research 2020. -
High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome
Autors:Referència: Journal Of Thoracic Oncology 2020. -
Clinical Relevance of an Amplicon-Based Liquid Biopsy for Detecting ALK and ROS1 Fusion and Resistance Mutations in Patients With Non-Small-Cell Lung Cancer
Autors:Referència: Jco Precision Oncology 2020. -
Indoor Radon in EGFR- and BRAF-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer Patients
Autors:Referència: Clinical Lung Cancer 2019. -
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Autors:Referència: Jama Oncology 2018.
Projectes destacats
-
Estudio EXPOS: Exposoma y medicina de precisión en pacientes con cáncer portadores de fusiones oncogénicas: entendiendo el papel de los carcinógenos y su implicación
Investigador/a principal: Laura Mezquita PérezDurada: 01/01/2024 -
Exposome & Precision Medicine in lung Cancer: understanding the role of carcinogens in clinical care
Investigador/a principal: Laura Mezquita PérezDurada: 01/01/2024 -
Impact of circulating neutrophils and tumor-associated neutrophils (TAN) in untreated advanced NSCLC treated with inmunotherapy and /or chemotherapy
Investigador/a principal: Laura MezquitaFinançador: SEOM (Socieadad Española de Oncología Médica)Durada: 31/10/2021